Satisfaction and Impact on Quality of Life of Clinical and Instrumental Surveillance and Prophylactic Surgery in BRCA-mutation Carriers

Risks and Benefits of Estrogen Plus Progestin in Healthy Postmenopausal Women: Principal Results From the Women's Health Initiative Randomized Controlled Trial

JAMA · 2002 · 15.8K citations · Full text

Medicine, Endocrinology, Pharmacotherapy +17

Association of Risk-Reducing Surgery in <emph type="ital">BRCA1</emph> or <emph type="ital">BRCA2</emph> Mutation Carriers With Cancer Risk and Mortality

Susan M. Domchek · JAMA · 2010 · 1.5K citations · Full text

Medicine, Gynecology, Oncology +17

Bilateral Prophylactic Mastectomy Reduces Breast Cancer Risk in <i>BRCA1</i> and <i>BRCA2</i> Mutation Carriers: The PROSE Study Group

Timothy R. Rebbeck, Tara M. Friebel, Henry T. Lynch et al. · Journal of Clinical Oncology · 2004 · 1.1K citations

Medicine, Oncology, Surgery +17

The 2017 hormone therapy position statement of The North American Menopause Society

The North American Menopause Society · Menopause The Journal of The North American Menopause Society · 2017 · 990 citations

Medicine, Endocrinology, Pharmacotherapy +17

2016 IMS Recommendations on women’s midlife health and menopause hormone therapy

Rod Baber, Nick Panay, Anna Fenton · Climacteric · 2016 · 959 citations

Medicine, Endocrinology, Gynecology +11